The pandemic was far from Dr Alena's only challenge on a far-flung archipelago in the Philippines.

Amy Schumer has opened up about the reason why she stopped taking Ozempic, as she urged celebrities to be honest about their weight loss. The 43-year-old actor and comedian appeared on Watch What Happens Live with Andy Cohen on Thursday (8 June), where she revealed that tried taking the type 2 diabetes drug Ozempic for weight loss last year. “Like a year ago, I tried it,” she told Cohen, before admitting that she stopped taking the FDA-approved medication because of its side effects. “I was one of those people that felt so sick and couldn’t play with my son,” Schumer explained, referring to her four-year-old son Gene, who she shares with husband Chris Fischer. “I was so skinny and he’s throwing a ball at me and [I couldn’t].” Although the Trainwreck star admitted that she was “immediately invested” before trying the drug, she ultimately decided that Ozempic wasn’t “livable” for her. However, Schumer did take a moment to call out celebrities who have been “lying” about taking the once-weekly antidiabetic injection for weight loss. “Everyone’s like: ‘Smaller portions,’” she joked. “Shut the f*** up. You’re on Ozempic, or one of those things.” Much like Ozempic, FDA-approved medications Wegovy and Mounjaro are also brand names for semaglutide – which work by mimicking a hormone that regulates appetite and creates the feeling of fullness. “Just stop,” Schumer added. “Just be real with the people.” The Inside Amy Schumer star even noted how she was open about undergoing liposuction for weight loss in January 2022. “When I got lipo, I was like, I got lipo,” she said. Ozempic, a once-weekly injection used for the treatment of type 2 diabetes, has skyrocketed in use after people were reportedly prescribed the diabetes medication as an “off-label” weight loss drug. Meanwhile, Wegovy and Mounjaro are once-weekly semaglutide injections specifically approved for the treatment of obesity and weight loss. There are many side effects of taking medications like Ozempic, Wegovy, and Mounjaro. According to the US Food and Drug Administration (FDA), the most common side effects of taking Wegovy include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, and digestive disorders. The FDA has also warned against more serious complications that can occur from using Wegovy or Mounjaro, such as the “potential risk of thyroid C-cell tumours,” pancreatitis, gallbladder problems, acute kidney injury, increased heart rate, and suicidal behaviour or thinking. Meanwhile, taking Ozempic can lead to possible thyroid tumours, including cancer, pancreatitis, changes in vision, and kidney and gallbladder problems. Amy Schumer isn’t the only celebrity to open up about taking certain medications for weight loss. Comedian Chelsea Handler previously revealed that she “didn’t know” she was on Ozempic because her doctor allegedly “hands it out to anybody”. During an appearance on Alex Cooper’s Call Her Daddy podcast in January, the Chelsea Lately star spoke candidly about the alleged widespread use of Ozempic in Hollywood and her concerns over its popularity. “So, my anti-ageing doctor just hands it out to anybody,” Handler claimed. “I didn’t even know I was on it. She said: ‘If you ever want to drop five pounds, this is good.’” She said she realised she was taking the type 2 diabetes drug for weight loss after feeling nauseous while at lunch with a friend, who was also on Ozempic. When her friend asked if Handler was taking the medication, which the comedian referred to as “semaglutide” during their conversation, her friend informed her Ozempic was simply a brand name for semaglutide. However, Handler said she stopped taking the medication after she realised what it was. “I’m not on it anymore. That’s too irresponsible,” she shared. “I’m an irresponsible drug user, but I’m not gonna take a diabetic drug. I tried it, and I’m not gonna do that. That’s not for me. That’s not right for me.” Read More Vanderpump Rules star Brittany Cartwright addresses rumours she’s taking Ozempic for weight loss FDA warns against using off-brand versions of Ozempic, Wegovy for weight loss Mark Wahlberg says he prefers to stay in shape ‘the old-fashioned way’ as he weighs in on Ozempic trend Debate sparker over parent who wouldn’t give her daughter any birthday cake Everything you need to know about hay fever How to protect pets from wildfire smoke amid air quality alert

Can your MacGyver air scrubber do the work of a purifier costing hundreds of dollars? Science says yes.

Pakistan’s cash-strapped government has presented its draft for the national budget, allocating funds to fight climate change despite staggering $30 billion in losses from last summer’s devastating floods

While co-founding two of the most influential HIV/AIDS organizations in the U.S., he still had time to pen a landmark play and be nominated for an Academy Award.

By Laura Sanicola New York lawmakers are considering legislation on Friday that would create the first market for

President Joe Biden is set to sign an executive order aiming to bolster job opportunities for military and veteran spouses whose careers are often disrupted by their loved ones’ deployments

French President Emmanuel Macron met with artificial intelligence experts from Meta Platforms Inc. and Alphabet Inc.’s Google, among

Former professional footballers are almost three and a half times more likely to be diagnosed with dementia than the general population, according to a study commissioned by the Football Association and Professional Footballers’ Association. First findings of the FOCUS study, conducted by the University of Nottingham, support previous research that former footballers may be at higher risk of neurocognitive disease. The new report states that 2.8 per cent of retired professional footballers in their study reported medically diagnosed dementia and other neurodegenerative disease compared to 0.9 percent of controls. This means former pros in the study were found to be 3.46 times more likely to have neurodegenerative diseases compared to the control group. The study also showed retired footballers in the study were twice as likely to fall below established thresholds in some dementia testing than the general population. Dr Charlotte Cowie, the FA’s head of medicine, told the governing body’s website: “The FA and the PFA jointly commissioned the FOCUS study in order to gain additional insight into the findings of the FIELD study, and to further examine any potential link between neurodegenerative disorders in former professional footballers. “The FOCUS study worked with an established group of former professional footballers that were participating in research and was able to review their brain health, and it supports the previous findings in the FIELD study which suggest an increased risk for neurodegenerative disease in former professional footballers than in the general population. “This is an extremely complex area of our game, but we are committed to working collectively with our stakeholders to help grow our knowledge in this area through further medical and expert analysis.” The initial findings of the FOCUS study will be shared with both FIFA and UEFA, and the FA has reiterated its support for further research from across the wider game to help build a better understanding of players’ brain health and well-being. “This is an important new study which supports previous evidence suggesting that footballers are at greater risk of dementia and poorer cognitive functioning in later life,” said the PFA’s head of brain health Dr Adam White. “Studies such as this… ensure that targeted and evidence-led action can be identified and taken to support and protect players at all stages of their career. “Continued investment in this type of research will remain absolutely vital.” An FA statement read: “The FA has led the way in taking steps to help reduce potential risk factors within the game (including) establishing industry-leading concussion guidelines, introducing the world’s most comprehensive heading guidance at every level of the professional and amateur game in England, and implementing a new trial to remove deliberate heading in football matches across under-12 level and below. “Further findings from the FOCUS study will be published in due course.”

NorthWestern Energy will resume construction of a natural gas power plant along Montana’s Yellowstone River following a two-month delay

ROCKVILLE, Md.--(BUSINESS WIRE)--Jun 9, 2023--

With AI rapidly becoming a buzzword across industries, oil and gas companies are exploring ways to use this